I applaud the agency for finally taking formal action to change its LDT policy by issuing the notification of its impending guidance.
Editor's note · Context
Waxman supports FDA's new guidance on laboratory developed tests (LDTs) after a long wait.
Share
More from Henry Waxman
Because of the time when nothing was being done to address global warming, we are now faced with the fact that tomorrow is today.
Today's hearing is about the Children's Health Insurance Program. This is a rare program in Washington that has enjoyed bipartisan support since its inception in 1997.
We need to find answers to these questions, and I hope the committee will continue its investigation even after the time you and I, Mr. Chairman, will be gone.
So what we are seeing is something that sounds good from a party that has no credibility to say that they are for more science information. What they would do is limit what EPA would be able to use to determine, based on the science, what…





